Patent · US Active

Thienopyrimidines

US9540392B2 · kind B2 · utility

1Cited by

3References

10Claims

0Family size

Assignee

Bayer Pharma Aktiengesellschaft · DE

Inventors

Georg Kettschau · Berlin, DE
Florian Puehler · Wellesley, US
Knut Eis · Berlin, DE
Ulrich Klar · Berlin, DE
Dirk Kosemund · Berlin, DE
Detlev Sülzle · Berlin, DE
Philip Lienau · Berlin, DE
Andrea Hägebarth · Berlin, DE
Ulf Bömer · Glienicke, DE
Lars Wortmann · Berlin, DE
Keith Graham · Berlin, DE
Antje Margret Wengner · Berlin, DE

Key dates

Filing date	May 17, 2013
Grant date	Jan 10, 2017
Priority date	—
Expiry date	May 17, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to substituted thienopyrimidine compounds of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.